BALAXI.NS

Balaxi Pharmaceuticals Limited

NSEHealthcare

₹23.66

▼ -1.95%-₹0.47 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹24.13

Day range

₹0 – ₹0

52W range

₹15.2 – ₹52.5

Volume

36.4K

Avg vol (20D)

2.1L

Mkt cap

₹130.68Cr

P/E TTM

91.0×

Trade Balaxi Pharmaceuticals Limited with Artha

Company Metrics

Revenue (ttm)₹270.17 Cr

Net Income (ttm)₹0.00

Shares Out5.52 Cr

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.70

About BALAXI.NS

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

Employees0

Stock ExchangeNSE

Ticker SymbolBALAXI.NS

Websitehttps://balaxipharma.in

BALAXI.NS · NSE

Financial Performance

In 2026, Balaxi Pharmaceuticals Limited's revenue was ₹270.17 Cr, an decrease of +7.30% compared to the previous year. Earnings were ₹0.00, an decrease of +92.90%.

Revenue (2026)

₹270.17 Cr

↘-7.30% YoY

Earnings (2026)

₹0.00

↘-92.90% YoY

Year-over-Year Growth

Revenue

-7.30%

Earnings

-92.90%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account